People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Avedro Inc | — | Other Health Care | Series C | $158.4M | $571.6M | 2018 |
| Revision Optics Inc | — | Other Technology | Series B | $121.7M | $973.8M | 2010 |
| Doximity, Inc. | — | Other Technology | Series B | $27.2M | $519.3M | 2012 |
| Lensx Lasers Inc | — | Biotechnology | Series B | $22.4M | $887.5M | 2009 |
Gilbert Kliman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Gilbert Kliman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Gilbert H. Kliman | 2 | 5 |
| Robert Palmisano | 2 | 3 |
| Wende Hutton | 1 | 16 |
| Garheng Kong | 1 | 16 |
| William Link | 1 | 11 |
| Jonathan Silverstein | 1 | 10 |
| Gordon Ritter | 1 | 8 |
| Brian H. Dovey | 1 | 7 |
| Reza Zadno | 1 | 7 |
| Brian Dovey | 1 | 7 |
| Doug Cole | 1 | 6 |
| Philip J. Ferneau | 1 | 6 |
| Anthony J. Natale | 1 | 5 |
| Frank Fischer | 1 | 5 |
| Joseph Mandato | 1 | 5 |
| Hongbo Lu | 1 | 4 |
| Frank M. Fischer | 1 | 4 |
| Robert J. Palmisano | 1 | 3 |
| Shelley Thunen | 1 | 3 |
| Kevin Spain | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.